Monica Calderón-Goercke

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 109 citations · Full text

Life Sciences, Pharmacotherapy, Surgery +6

Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica

D. Prieto-Peña, I. Martínez‐Rodríguez, J. Loricera et al. · Seminars in Arthritis and Rheumatism · 2018 · 103 citations

Medicine, Internal Medicine, Radiology +13

Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis

Diana Prieto Peña, I. Martínez‐Rodríguez, Belén Atienza‐Mateo et al. · Clinical and Experimental Rheumatology · 2021 · 51 citations · Full text

Medicine, Radiology, Diagnostic Imaging +6

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · PubMed · 2020 · 34 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy

D. Prieto-Peña, Monica Calderón-Goercke, Alfredo Adán et al. · Clinical and Experimental Rheumatology · 2021 · 32 citations · Full text

Medicine, Immunology, Obstetrics +15